EENT · PANCE / PANRE

Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity)

Persistent oral ulcer, mass, or red/white patch in a smoker or heavy drinker — biopsy any lesion not healed in 2 weeks.

Also known as: oral cancer, oral squamous cell carcinoma, oral SCC, tongue cancer, floor of mouth cancer

Overview

Malignancy arising from the mucosa of the oral cavity, including the lips, anterior two-thirds of the tongue, buccal mucosa, floor of mouth, hard palate, gingiva, and retromolar trigone. More than 90% are squamous cell carcinomas.

Epidemiology

Roughly 35,000-55,000 new oral and oropharyngeal cancer cases annually in the United States; male predominance roughly 2-3:1; median age at diagnosis approximately 63. The tongue (lateral border) and floor of the mouth are the most common subsites. Five-year survival is highly stage-dependent: greater than 80% for localized disease but less than 40% for regional or distant disease.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Tobacco use (cigarettes, cigars, pipe, smokeless tobacco) — strongest modifiable risk factor
  • Heavy alcohol use (synergistic with tobacco)
  • Betel nut chewing
  • HPV — primarily associated with oropharyngeal SCC (tonsil, base of tongue) rather than true oral cavity SCC, but increasingly relevant
  • Sun exposure (lip cancer)
  • Premalignant lesions: leukoplakia, erythroplakia, oral lichen planus, submucous fibrosis
  • Immunosuppression (transplant, HIV)
  • Prior head and neck radiation

Pathophysiology

Chronic mucosal exposure to carcinogens drives a stepwise accumulation of mutations (TP53, CDKN2A, NOTCH1, PIK3CA) through hyperplasia, dysplasia, carcinoma in situ, and invasive carcinoma. Lymphatic spread to cervical nodes is common; the depth of invasion correlates with the risk of nodal metastasis and prognosis.

Clinical presentation

Symptoms

  • Non-healing oral ulcer or mass present for more than 2-3 weeks
  • Persistent oral pain, often dull and progressively worse
  • Bleeding, loose teeth, or ill-fitting dentures
  • Otalgia (referred pain via the auriculotemporal branch of CN V3 and via CN IX/X)
  • Dysphagia, odynophagia, trismus suggests advanced disease
  • Neck mass (cervical lymphadenopathy) may be the presenting sign

Signs / physical exam

  • Indurated ulcer with rolled, raised, irregular borders
  • Red, white, or mixed (erythroleukoplakic) patch that does not wipe off
  • Exophytic or endophytic mass, especially on the lateral tongue or floor of mouth
  • Palpable firm, fixed cervical lymphadenopathy (levels I-III most often)
  • Reduced tongue mobility or numbness in a trigeminal distribution
  • Trismus suggests pterygoid invasion

Classic findings

Persistent, painless, indurated ulcer on the lateral tongue or floor of mouth in a smoker.

Differential diagnosis

  • Aphthous ulcer — Small, painful, round ulcer with white pseudomembrane and erythematous halo; self-limited within 2 weeks
  • Traumatic ulcer — History of biting or denture trauma; resolves once the trauma is removed
  • Herpetic ulcers — Multiple small vesicles that coalesce; keratinized mucosa primarily; recurrent; vesicular phase distinguishes
  • Oral lichen planus — Bilateral lace-like white striae (Wickham) or erosive plaques; chronic and symmetrical; biopsy if atypical or persistent
  • Leukoplakia and erythroplakia (premalignant) — Painless white or red mucosal patches that cannot be wiped off; high malignant transformation rate for erythroplakia
  • Necrotizing sialometaplasia — Sudden palatal ulcer in a smoker or after dental procedure; benign and self-resolving but mimics SCC histologically
  • Salivary gland tumor or minor salivary gland malignancy — Submucosal mass without surface ulceration; biopsy
  • Syphilitic chancre or gumma — Painless ulcer; serology (RPR, treponemal tests)

Diagnostic workup

Diagnostic criteria

Histologic confirmation by incisional or excisional biopsy. Staging follows AJCC 8th edition TNM system, incorporating depth of invasion and extranodal extension.

Labs

  • CBC, comprehensive metabolic panel, coagulation studies, type and screen for preoperative planning
  • HPV/p16 testing of biopsy tissue (although primarily relevant for oropharyngeal SCC, increasingly studied in oral cavity SCC)
  • Nutritional assessment (albumin, prealbumin) if weight loss

Imaging

  • Direct visualization and incisional biopsy of suspicious lesions — biopsy any lesion that has not healed within 2-3 weeks
  • Contrast-enhanced CT of neck — primary staging modality for tumor extent and cervical nodes
  • MRI of the primary site for soft tissue and perineural invasion (preferred for tongue and floor of mouth)
  • PET/CT for staging in advanced disease and to assess for distant metastasis or second primary
  • Panoramic radiograph for mandibular involvement
  • Examination under anesthesia with panendoscopy to evaluate for synchronous second primary lesions

Diagnostic algorithm

flowchart TD
  A[Suspicious oral lesion<br/>not healed at 2-3 weeks] --> B[Incisional biopsy]
  B --> C{SCC confirmed?}
  C -->|No| D[Treat alternative cause<br/>re-examine 2-4 weeks]
  C -->|Yes| E[CT neck + MRI<br/>+ PET/CT if advanced]
  E --> F{Stage}
  F -->|I-II| G[Surgery ± selective<br/>neck dissection]
  F -->|III-IVA/B| H[Surgery + adjuvant<br/>(chemo)radiation]
  F -->|IVC| I[Systemic therapy<br/>palliative care]
  G --> J[Surveillance per NCCN]
  H --> J
Diagnostic and treatment pathway for oral squamous cell carcinoma.

Treatment

First-line

  • Surgical resection of the primary lesion with adequate margins (typically 1 cm clinically, with frozen-section margins) — mainstay for early-stage disease
  • Neck dissection (selective or modified radical) for clinically positive nodes or for primary tumors with significant depth of invasion (generally greater than 3-4 mm)
  • Postoperative radiation therapy (with or without concurrent platinum-based chemotherapy) for advanced T-stage, positive or close margins, extranodal extension, perineural invasion, or multiple positive nodes

Second-line / adjunct

  • Reconstruction (radial forearm, fibula, or anterolateral thigh free flaps) for functional preservation
  • Speech and swallowing therapy, dental rehabilitation
  • Smoking and alcohol cessation counseling
  • Surveillance per NCCN: clinical exam every 1-3 months in year 1, every 2-6 months in year 2, every 4-8 months in years 3-5, then annually

Complications

  • Locoregional recurrence (highest risk in the first 2 years)
  • Second primary head and neck or lung malignancy
  • Chronic dysphagia, aspiration, xerostomia after radiation
  • Osteoradionecrosis of the mandible
  • Disfigurement and speech impairment
  • Cervical lymphedema
  • Nutritional decline and weight loss

PANCE pearls

  • Biopsy any oral lesion that has not healed in 2-3 weeks — do not assume aphthous ulcer.
  • The lateral tongue and floor of the mouth are the highest-risk subsites.
  • Erythroplakia carries the highest malignant transformation risk of premalignant lesions.
  • Refer any persistent neck mass in an adult older than 40 with risk factors for prompt workup — assume metastatic SCC until proven otherwise.
  • Tobacco and alcohol cessation reduces second primary risk substantially.

References

  • NCCN — NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (current version)
  • AAO-HNS — American Academy of Otolaryngology-Head and Neck Surgery resources on oral cavity malignancy
  • AJCC — AJCC Cancer Staging Manual, 8th edition (Amin et al., Springer 2017)

Practice EENT questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.